1 study on Alpha msh analog mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
**Bremelanotide's central mechanism of action** — activating `melanocortin receptors` in the hypothalamus rather than relaxing peripheral vasculature — means it avoids the hypotensive liability that limits PDE5 inhibi…